Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01474577 · ClinicalTrials.gov registry record
Prognostic Value of Rb-82 PET Myocardial Perfusion Imaging
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 57
- Enrollment target
NCT01474577: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01474577 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 57 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01474577 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 57 participants
- Enrollment target
Study Summary
The physician would like to see if nuclear cardiac stress tests can predict cardiac health. For example, if a patient has an abnormal stress test, is he or she more likely to have cardiac problems in the future?
Interventions
- OTHER questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2011-11-08 |
| Est. Completion | 2017-05-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01474577
The ClinicalTrials.gov registry entry for NCT01474577 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which questionnaire is the first listed.
NCT01474577 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01474577 about?
NCT01474577 is a clinical study titled "Prognostic Value of Rb-82 PET Myocardial Perfusion Imaging". The physician would like to see if nuclear cardiac stress tests can predict cardiac health. For example, if a patient has an abnormal stress test, is he or she more likely to have cardiac problems in the future?
What is the current status of trial NCT01474577?
This trial is currently completed. The enrollment target is 57 participants. The study started on 2011-11-08. Estimated completion is 2017-05-18.
What interventions are being tested in trial NCT01474577?
The interventions under investigation include: questionnaire (OTHER).
Who is sponsoring clinical trial NCT01474577?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.